The Fetal Medicine Foundation 15th World Congress in Fetal Medicine
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • High NT
    • Syndromes
    • Placenta
    • Other
    • All
    • Face
    • Heart
    • Lungs
    • Abdominal wall
    • Gastrointestinal
    • Renal
    • Skeleton
    • Tumors
  • Fetal therapy
  • Impaired placentation
  • Congenital infections
  • GDM / obesity
  • Maternal conditions
  • Preterm birth
  • Labour / delivery
  • Multiple pregnancies
  • Other

Aneuploidies

  1. French health law on serum freezing impact on Immulite PAPP-A assay for trisomy 21 screening View pdf
  2. Implementation models of screening for aneuploidies View pdf
  3. Semi-automated measuring methods of nuchal translucency by TOSHIBA ultrasound units View pdf
  4. Clinical and cost effectiveness of prenatal diagnosis of chromosomal abnormalities in the Russian Federation View pdf
  5. Prenatal diagnosis of triploidy – experience of single referral centre View pdf
  6. Amniocentesis indications in patients below 35 years old View pdf
  7. Implementation of a contingent strategy for the screening of aneuploidies: two year experience View pdf
  8. A case of Klinefelter syndrome View pdf
  9. The association between assisted reproduction techniques and structural and chromosomal defects View pdf
  10. The impact of nuchal cord on ductus venosus assessment at 11 to 13+6 gestational weeks View pdf
  11. Screening for trisomy 21 in twin pregnancies in the first trimester View pdf
  12. A Schizencephaly Case Accompanied By Deletion of Chromosome 22q13. 32 View pdf
  13. A case of trisomy 9 View pdf
  14. Experience of a reference Fetal Medicine Service from Southern Brazil with pregnant women who underwent fetal karyotyping View pdf
  15. Fetal gender-adjusted PAPP-A and free b-hCG in euploid and aneuploid fetuses View pdf
  16. The role of ultrasound in early assessment of risk of miscarriage in aneuploid pregnancies View pdf
  17. Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach View pdf
  18. Assessment of stem markers and epigenetic environment in amniotic fluid in normal and abnormal fetuses View pdf
  19. A case of DiGeorge syndrome associated with a CNS malformation View pdf
  20. The impact of a two stage approach for first trimester Down syndrome screening View pdf
  21. Prevalence of fetal polymorphism in north western part of Turkey View pdf
  22. Evaluation compatibility of screening tests in first and second trimester with amniocentesis and pregnancy outcome View pdf
  23. Women’s preference after a high risk screening test result for fetal Down syndrome: Microarray vs. NIPT View pdf
  24. Two cases of de novo, interstitial duplications of 10q24. 32 View pdf
  25. Procedure Related Fetal Loss Following Chorionic Villus Sampling After Screening For Down Syndrome View pdf
  26. Does increased hepatic artery flow in first trimester fetuses signal an adverse outcome View pdf
  27. Clinical significance of high risk result for trisomy 21 in triple test in the absence of aneuploidy View pdf
  28. Nitrous oxide decreases anxiety in women undergoing chorionic villus sampling View pdf
  29. Fetal triploidy with barely altered phenotype View pdf
  30. A case of prenatal diagnosis of Patau syndrome View pdf
  31. A case of an unexpected diagnosis of turner mosaicism View pdf
  32. Invasive tests and results in our area View pdf
  33. Relationship between chorionic villus sampling and placental pathology View pdf
  34. First trimester ultrasound assessmnet and congenital anomalies View pdf
  35. The changes in ultrasound findings on the central nervous system in fetus with chromosomal abnormality View pdf
  36. Variability of clinical manifestation in patients with Di George's syndrome View pdf
  37. BoBs: The application of the new rapid prenatal diagnosis technology research View pdf
  38. Small cerebellum and abnormal first trimester biochemistry in a pregnancy affected by 5p deletion syndrome View pdf
  39. Increased prevalence of bicuspid aortic valve in turner syndrome links with karyotype: a crucial importance of detailed cardiovascular screening View pdf
  40. Fetal karyotyping and CMA indicated for late onset abnormal sonographic findings are they really necessary? View pdf
  41. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling View pdf
  42. 22q11 microdeletion: A review of ultrasound findings and the relation with diagnostic prenatal testing View pdf
  43. How safe is late amniocentesis preformed after 24 weeks of gestation? View pdf
  44. Does the magnitude of increased nuchal translucency affect the likelihood of chromosomal anomalies? View pdf
  45. Collagen type IV in the pathogenesis of increased prenasal thickness in Trisomy 21 fetuses View pdf
  46. Establishment of mass screening for aneuploidies by serum markers in the governorate of Bizerte, northern Tunisia View pdf
  47. Prenatal diagnosis using array comparative genomic hybridization analysis in high risk pregnancies View pdf
  48. Pregnancy outcome in amniocentesis and chorionic villous sampling: 10-year report View pdf
  49. New markers calculation of risk during screening ultrasound I trimester of pregnancy View pdf
  50. Computational Intelligent Screening for Chromosomal Abnormalities of the Fetus View pdf
  51. A case of 47, XYY in association with congenital anomalies in teenage couple View pdf
  52. Assessment of a rapid aneuploidy diagnosis by the BACs-on-Beads TM assay during late pregnancy View pdf
1693167816751672166916671660165416371636163316321622160815931588158515831581157515741567156615621540153415261495147214691467146514641441141414111405140013771372136113391302129412881281125512161206120011951189
© 2016 The Fetal Medicine Foundation